SS

Seema Sikka

Active Director Director DIN 08236113
DIN 08236113 First appointment Sep 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Seema Sikka

Data last updated:

Seema Sikka is a Director at Devesh Meditech Private Limited (since 2018). The company operates in Healthcare. Devesh Meditech Private Limited reported revenue of ₹1.99 Cr (FY 2024).

DIN 08236113
Primary Designation Director
Industry Healthcare
First Appointment 24 Sep 2018
Oldest Company Age 8 yrs
Largest company Devesh Meditech Private Limited · ₹1.99 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Devesh Meditech Private Limited U51909DL2018PTC339345
Director24 Sep 20182018₹1.99 Cr (FY 2024)Active

Board colleagues of Seema Sikka

NameDINCompanyDesignation
Sumit Sikka08236092Devesh Meditech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Devesh Meditech Private Limited
Premium access

Shareholding and investment profile for Seema Sikka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Sikka

Seema Sikka currently holds 1 directorship: Devesh Meditech Private Limited (Director, since 24 Sep 2018, revenue ₹1.99 Cr (FY 2024)).

Seema Sikka was first appointed on 24 Sep 2018 as Director at Devesh Meditech Private Limited.

The current boards of Seema Sikka's companies include Sumit Sikka (Devesh Meditech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available